These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34417259)

  • 1. Acute Myeloid Leukemia Alters Group 1 Innate Lymphoid Cell Differentiation from a Common Precursor.
    Lordo MR; Wu KG; Altynova E; Shilo N; Kronen P; Nalin AP; Weigel C; Zhang X; Yu J; Oakes CC; Caligiuri MA; Freud AG; Mundy-Bosse BL
    J Immunol; 2021 Sep; 207(6):1672-1682. PubMed ID: 34417259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function.
    Scoville SD; Nalin AP; Chen L; Chen L; Zhang MH; McConnell K; Beceiro Casas S; Ernst G; Traboulsi AA; Hashi N; Williams M; Zhang X; Hughes T; Mishra A; Benson DM; Saultz JN; Yu J; Freud AG; Caligiuri MA; Mundy-Bosse BL
    Blood; 2018 Oct; 132(17):1792-1804. PubMed ID: 30158248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic IL-15 Stimulation and Impaired mTOR Signaling and Metabolism in Natural Killer Cells During Acute Myeloid Leukemia.
    Bou-Tayeh B; Laletin V; Salem N; Just-Landi S; Fares J; Leblanc R; Balzano M; Kerdiles YM; Bidaut G; Hérault O; Olive D; Aurrand-Lions M; Walzer T; Nunès JA; Fauriat C
    Front Immunol; 2021; 12():730970. PubMed ID: 34975835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML.
    Salomé B; Gomez-Cadena A; Loyon R; Suffiotti M; Salvestrini V; Wyss T; Vanoni G; Ruan DF; Rossi M; Tozzo A; Tentorio P; Bruni E; Riether C; Jacobsen EM; Jandus P; Conrad C; Hoenig M; Schulz A; Michaud K; Della Porta MG; Salvatore S; Ho PC; Gfeller D; Ochsenbein A; Mavilio D; Curti A; Marcenaro E; Steinle A; Horowitz A; Romero P; Trabanelli S; Jandus C
    Blood Adv; 2019 Nov; 3(22):3674-3687. PubMed ID: 31765481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells.
    Hughes T; Briercheck EL; Freud AG; Trotta R; McClory S; Scoville SD; Keller K; Deng Y; Cole J; Harrison N; Mao C; Zhang J; Benson DM; Yu J; Caligiuri MA
    Cell Rep; 2014 Jul; 8(1):150-62. PubMed ID: 24953655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of aryl hydrocarbon receptor (AhR) in mesenchymal stem cells modulates macrophage polarization in asthma.
    Cui Z; Feng Y; Li D; Li T; Gao P; Xu T
    J Immunotoxicol; 2020 Dec; 17(1):21-30. PubMed ID: 31922435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aryl hydrocarbon receptor mediates Jak2/STAT3 signaling for non-small cell lung cancer stem cell maintenance.
    Xiong J; Zhang X; Zhang Y; Wu B; Fang L; Wang N; Yi H; Chang N; Chen L; Zhang J
    Exp Cell Res; 2020 Nov; 396(1):112288. PubMed ID: 32941808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of CH223191-Induced Mitochondrial Dysfunction on Its Aryl Hydrocarbon Receptor Agonistic and Antagonistic Activities.
    Mohammadi-Bardbori A; Omidi M; Arabnezhad MR
    Chem Res Toxicol; 2019 Apr; 32(4):691-697. PubMed ID: 30793600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.
    Cianga VA; Campos Catafal L; Cianga P; Pavel Tanasa M; Cherry M; Collet P; Tavernier E; Guyotat D; Rusu C; Aanei CM
    Front Immunol; 2021; 12():665541. PubMed ID: 33986753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model.
    Dinallo V; Marafini I; Di Fusco D; Di Grazia A; Laudisi F; Dwairi R; Paoluzi OA; Monteleone G; Monteleone I
    Front Immunol; 2019; 10():91. PubMed ID: 30778350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation.
    Sudan R; Gilfillan S; Colonna M
    Immunol Rev; 2024 May; 323(1):107-117. PubMed ID: 38563448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLZF expression maps the early stages of ILC1 lineage development.
    Constantinides MG; Gudjonson H; McDonald BD; Ishizuka IE; Verhoef PA; Dinner AR; Bendelac A
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5123-8. PubMed ID: 25838284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
    Gentil M; Hugues P; Desterke C; Telliam G; Sloma I; Souza LEB; Baykal S; Artus J; Griscelli F; Guerci A; Johnson-Ansah H; Foudi A; Bennaceur-Griscelli A; Turhan AG
    PLoS One; 2018; 13(8):e0200923. PubMed ID: 30091999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
    Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
    J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoids inhibit human hematopoietic stem cell differentiation toward a common ILC precursor.
    Quatrini L; Tumino N; Besi F; Ciancaglini C; Galaverna F; Grasso AG; Merli P; Locatelli F; Vacca P; Moretta L
    J Allergy Clin Immunol; 2022 May; 149(5):1772-1785. PubMed ID: 34688777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-kynurenine/aryl hydrocarbon receptor pathway mediates brain damage after experimental stroke.
    Cuartero MI; Ballesteros I; de la Parra J; Harkin AL; Abautret-Daly A; Sherwin E; Fernández-Salguero P; Corbí AL; Lizasoain I; Moro MA
    Circulation; 2014 Dec; 130(23):2040-51. PubMed ID: 25359166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-29b mediates altered innate immune development in acute leukemia.
    Mundy-Bosse BL; Scoville SD; Chen L; McConnell K; Mao HC; Ahmed EH; Zorko N; Harvey S; Cole J; Zhang X; Costinean S; Croce CM; Larkin K; Byrd JC; Vasu S; Blum W; Yu J; Freud AG; Caligiuri MA
    J Clin Invest; 2016 Dec; 126(12):4404-4416. PubMed ID: 27775550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells play a significant role in immunosurveillance at the early stage of MLL-AF9 acute myeloid leukemia via CD226/CD155 interactions.
    Wang Y; Chen C; Dong F; Ma S; Xu J; Gong Y; Cheng H; Zhou Y; Cheng T; Hao S
    Sci China Life Sci; 2015 Dec; 58(12):1288-98. PubMed ID: 26588911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells.
    Veldhoen M; Hirota K; Christensen J; O'Garra A; Stockinger B
    J Exp Med; 2009 Jan; 206(1):43-9. PubMed ID: 19114668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.